KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.87 $1.65 Friday, 26th Apr 2024 ADAP stock ended at $1.08. This is 1.42% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.83% from a day low at $1.03 to a day high of $1.09.
90 days $0.730 $2.05
52 weeks $0.420 $2.05

Historical Adaptimmune Therapeutics plc prices

Date Open High Low Close Volume
Mar 26, 2021 $5.26 $5.31 $4.91 $5.13 998 700
Mar 25, 2021 $5.00 $5.29 $4.75 $5.25 994 589
Mar 24, 2021 $5.50 $5.51 $5.01 $5.07 729 439
Mar 23, 2021 $5.80 $5.86 $5.32 $5.38 1 275 295
Mar 22, 2021 $5.30 $6.05 $5.20 $5.72 1 623 204
Mar 19, 2021 $5.28 $5.39 $5.08 $5.17 985 970
Mar 18, 2021 $5.29 $5.56 $5.15 $5.20 587 456
Mar 17, 2021 $5.29 $5.49 $5.05 $5.41 601 751
Mar 16, 2021 $5.37 $5.50 $5.16 $5.34 638 699
Mar 15, 2021 $5.47 $5.58 $5.30 $5.36 573 145
Mar 12, 2021 $5.52 $5.54 $5.24 $5.48 464 452
Mar 11, 2021 $5.40 $5.55 $5.35 $5.53 501 349
Mar 10, 2021 $5.44 $5.60 $5.26 $5.30 428 008
Mar 09, 2021 $5.00 $5.39 $5.00 $5.32 773 633
Mar 08, 2021 $5.14 $5.18 $4.86 $4.90 721 212
Mar 05, 2021 $5.01 $5.13 $4.52 $5.13 1 310 472
Mar 04, 2021 $5.28 $5.32 $4.79 $5.01 1 178 064
Mar 03, 2021 $5.40 $5.55 $5.25 $5.25 611 263
Mar 02, 2021 $5.69 $5.77 $5.41 $5.43 637 972
Mar 01, 2021 $5.66 $5.99 $5.62 $5.73 559 932
Feb 26, 2021 $5.90 $6.12 $5.50 $5.54 913 707
Feb 25, 2021 $6.02 $6.13 $5.75 $5.94 562 493
Feb 24, 2021 $6.07 $6.12 $5.80 $5.99 560 818
Feb 23, 2021 $5.93 $6.03 $5.36 $5.95 1 032 972
Feb 22, 2021 $6.15 $6.46 $6.07 $6.12 850 006
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT